Related Experiment Video
Updated: Jun 6, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Autologous hematopoietic stem cell transplantation in type 1-diabetes
Anders H Rosengren1, Erik Renström
1Lund University Diabetes Centre, Malmö, Sweden.
Abstract:
A type 1-diabetes results from autoimmune destruction of the insulin producing ß-cells in the pancreas. Today there is no cure to the disorder, and the patients require life-long insulin medication to survive. Treatment with exogenous insulin cannot mimic the second-by second regulation of blood glucose levels achieved by the ß-cells, and the current regimen presents a difficult navigation between the Scylla of life-threatening hypoglycemia and the Charybdis of hyperglycemic tissue glycosylation and late-complications.
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
